Anda belum login :: 23 Nov 2024 18:55 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junction
Oleh:
Lahiff, C.
;
Schilling, C
;
Cathcart, M.-C.
;
Mulligan, N.
;
Doran, P.
Jenis:
Article from Article - diterbitkan di jurnal ilmiah internasional
Dalam koleksi:
BJS: British Journal of Surgery vol. 101 no. 02 (Jan. 2014)
,
page 55-62.
Fulltext:
hal55-62.pdf
(226.0KB)
Ketersediaan
Perpustakaan FK
Nomor Panggil:
B15.K.2014.01
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Background: Neuroepithelial transforming gene 1 (NET1) mediates tumour invasion and metastasis in a number of cancers, including gastric adenocarcinoma. It is an indicator of poor prognosis in breast cancer and glioma. This study examined NET1 expression and its prognostic significance in patients with adenocarcinoma of the oesophagogastric junction (AOG). Methods: NET1 expression wasmeasured by immunohistochemistry in a tissuemicroarray, constructed from biobanked tissue collected over a 10-year interval, and linked to a prospectively maintained clinical database. Results: Using the Siewert classification for AOG, type I tumours expressed significantly higher levels of NET1, with lowest expression in type III and intermediate levels in type II (P =0·001). In patients with AOG type III, NET1-positive patients were more likely to be female (P =0·043), have advanced stage cancer (P =0.035), had a higher number of transmural cancers (P =0·006) and had a significantly higher median number of positive lymph nodes (P =0·029). In this subgroup, NET1-positive patients had worse median overall (15 versus 23 months; P =0·025) and disease-free (11 versus 36 per cent; P =0·025) survival compared with NET1-negative patients. Conclusion: Although existing data show differences in clinical and prognostic indices across AOG subtypes, there are no studies showing differences in tumour biology. These data suggest NET1, a known mediator of an aggressive tumour phenotype in a number of gastrointestinal cancers, is expressed differentially across AOG subtypes and may be of prognostic significance in the clinical management of this condition
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)